Loading clinical trials...
Loading clinical trials...
An observational analysis of Integra-treated burns and Novosorb Biodegradable Temporizing Matrix (BTM)-treated burns will be undertaken 12-36 months post final skin graft application by retrospectivel...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Integra LifeSciences Corporation
NCT07317271 · Burn, Chronic Pain Following Thermal Burn Injury, and more
NCT07050264 · Burn Injury, Body Temperature Regulation, and more
NCT07337616 · Burn Wounds - Partial Thickness (2nd Degree)
NCT06807021 · Burn Scar, Burn Wound
NCT05856994 · Burn Injury
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions